bringing car-t therapy in earlier lines of treatment in myeloma: karmma-3, cartitude-4 & cartitude-6
Published 1 year ago • 414 plays • Length 3:23Download video MP4
Download video MP3
Similar videos
-
2:57
strategies to optimize car-t therapy in myeloma: bringing car-t into earlier lines
-
2:03
car-t therapy in myeloma: moving into earlier lines and treating patients with unmet medical needs
-
1:06
moving car-t therapy to earlier lines in multiple myeloma and clinical trials in this space
-
1:01
the potentially curative role of car-t therapy in myeloma
-
9:58
the management & optimization of car t-cell therapy in myeloma
-
2:18
moving forward: bringing car-t therapy to a frontline setting in myeloma
-
2:48
an overview of the current landscape of car t-cell therapy in myeloma
-
1:15
ide-cel car t-cell therapy for r/r myeloma in karmma-3
-
6:23
how long will i live with multiple myeloma, and is there a cure? #myeloma
-
4:23
cancer car-t cell therapy, medical discovery of global relevance
-
4:12
car-t therapy in multiple myeloma: recent updates, clinical trials and future outlooks
-
2:23
improving car t-cell therapy for myeloma
-
4:42
car-t for myeloma: ongoing trials
-
2:01
car-t updates in myeloma
-
4:29
car-t therapy vs. asct for myeloma
-
0:54
ucartcs1: a novel allogeneic car-t therapy for myeloma
-
10:42
car t-cell therapy in myeloma
-
3:27
car-t cells in myeloma
-
1:15
the current status and future of car-t therapy in r/r myeloma
-
4:10
update on cartitude-1: car-t in rrmm
-
3:06
management of multiple myeloma during car-t therapy manufacturing
-
2:30
an update on the current status of car-t therapy in multiple myeloma